1. Inici
  2. Sistema de Salut de Catalunya
  3. Vall d'Hebron Institut d'Oncologia – VHIO
  4. Enviaments recents

Vall d'Hebron Institut d'Oncologia – VHIO: Enviaments recents

Ara mostrant els elements 1-20 de 464

    CD40 agonist mitazalimab with mFOLFIRINOX in untreated metastatic pancreatic cancer: Biomarkers associated with outcomes from OPTIMIZE-1 

    Van Laethem, Jean-Luc; Geboes, Karen; Borbath, Ivan; Lambert, Aurélien; Macarulla, Teresa; CASSIER, Philippe (Data de publicació: 2026-01-27)

    CD40 agonist; Biomarker; Chemotherapy

    Sex differences in the incidence trends of early-onset gastrointestinal cancer—the European/Mediterranean perspective 

    Ben-Aharon, Irit; Fokter Dovnik, Nina; Guren, Marianne; Gordon, Noa; van Laarhoven, H.W.M.; Baraibar, Iosune (Data de publicació: 2026-01-27)

    Sex differences; Early-onset gastrointestinal cancer

    Evaluation of the Safety, Pharmacokinetics, and Antitumor Activity of Tusamitamab Ravtansine in Patients With Nonsquamous NSCLC With High or Moderate Expression of Carcinoembryonic Antigen-Related Cell Adhesion Molecule 5 

    Gazzah, A.; Ricordel, Charles; Calvo, Emiliano; ITALIANO, ANTOINE; Cho, Byoung Chul; Kim, Dong-Wan; Vieito , Maria (Data de publicació: 2026-01-27)

    Antibody-drug conjugate; Carcinoembryonic antigen-related cell adhesion molecule 5; Non-small cell lung cancer

    Competencies for bioinformatics core facility scientists: extension of the ISCB competency framework for bioinformatics 

    Lloret-Llinares, Marta; Carvajal-López, Patricia; Downing, Tim; Gogol, Madelaine; Ho Sui, Shannan; Nonell, Lara (Data de publicació: 2026-01-27)

    Competencies; Bioinformatics

    USP10/GSK3β-mediated inhibition of PTEN drives resistance to PI3K inhibitors in breast cancer 

    Kumari, Nishi; Wright, Sarah Christine Elisabeth; Witham, Christopher; Monserrat, Laia; Palafox Sánchez, Marta; Richard, John L. C.; Serra, Violeta (Data de publicació: 2025-11-25)

    Breast cancer; Cell biology; Oncology

    Breastfeeding after breast cancer in young BRCA carriers 

    DELUCCHI, VIRGINIA; Ferrari, Alberta; Blondeaux, Eva; Mariamidze, Elene; Bernstein Molho, Rinat; Frank, Sophie; Balmaña, Judith (Data de publicació: 2025-11-24)

    Breastfeeding; Breast cancer; BRCA carriers

    Atezolizumab, bevacizumab, and platinum chemotherapy in cervical cancer: results of Japanese population from BEATcc 

    Takekuma, Munetaka; Nishio, Shin; Yamaguchi, Satoshi; Yunokawa, Mayu; Nishio, Hiroshi; Nishino, Koji; Villacampa Javierre, Guillermo; OAKNIN, ANA (Data de publicació: 2025-11-24)

    Angiogenesis Inhibitors; Atezolizumab; Bevacizumab

    Cabozantinib plus Atezolizumab in Advanced, Progressive Endocrine Malignancies: A Multicohort, Basket, Phase II Trial (CABATEN/GETNE-T1914) 

    Hernando, Jorge; BENAVENT VIÑUALES, MARTA; Capdevila Castillon, Jaume; Molina-Cerrillo, Javier; Garcia-Carbonero, Rocio; Teule, Alex (Data de publicació: 2025-11-21)

    Cabozantinib; Atezolizumab; Advanced progressive endocrine malignancies

    Randomized clinical efficacy and safety study of peltopepimut-S plus cemiplimab compared to cemiplimab alone in patients with recurrent/metastatic HPV16-positive head and neck cancer 

    Even, Caroline; Massarelli, Erminia; Laban, Simon; FAYETTE, Jérôme; Oliva Bernal, Marc; Harrington, Kevin; Brana, Irene (Data de publicació: 2025-11-11)

    Combination therapy; Head and neck cancer; Immune checkpoint inhibitor

    Retreatment with oxaliplatin-based regimens in refractory metastatic colorectal cancer: characterization of high-response patients 

    Catani, Greta; Alcaraz Soler, Adriana; García, Ariadna I.; Elez, Elena; Salvà, Francesc; Saoudi Gonzalez, Nadia; Baraibar, Iosune; Ros, Javier; R Castells, Marta; Salva de Torres, Clara; Comas Navarro, Raquel; Ruiz Pace, Fiorella; Rezqallah Arón , María Alejandra; Dienstmann, Rodrigo; Tabernero, Josep (Data de publicació: 2025-11-10)

    Oxaliplatin; Rechallenge; Reintroduce

    Preoperative immunotherapy with atezolizumab and tiragolumab in patients with colorectal liver metastases—the PURPLE trial 

    Elez, Elena; Neumann, Ulf; Lang, Sven Arke; Trampe, A. K.; Kasper, Stefan; Salvà, Francesc (Data de publicació: 2025-11-07)

    Colorectal liver metastases; Preoperative immunotherapy; Atezolizumab

    GOG-3097/ENGOT-ov81/GTG-UK/RAMP 301: a phase 3, randomized trial evaluating avutometinib plus defactinib compared with investigator’s choice of treatment in patients with recurrent low grade serous ovarian cancer 

    Moore, Kathleen; FABBRO, MICHEL; OMalley, David; Grisham, Rachel; Monk, Bradley; Van Nieuwenhuysen, Els (Data de publicació: 2025-11-06)

    Ovarian Cancer

    Clinical validation of liquid biopsy-RECIST (LB-RECIST) in metastatic colorectal cancer (mCRC) patients: findings from the PLATFORM-B study 

    MARTELLI, VALENTINO; vidal barrull, joana; Gibert Fernandez, Joan; Fernandez-Rodriguez, Concepción; Linares, Jenniffer; Elez, Elena; García-Alfonso, Pilar; Toledo, Rodrigo; Tabernero, Josep (Data de publicació: 2025-11-05)

    Liquid biopsy; Metastatic colorectal cancer; Response assessment

    Epigenetic synthetic lethality as a cancer therapeutic strategy: synergy of experimental and computational approaches 

    Fariña Morillas, Maria; Ollé i Monràs, Laia; de Rojas de Pablo, Isabel; Seoane Fernández, Jose Antonio; Maas, Silvana; Segura, Miguel F. (Data de publicació: 2025-11-03)

    Synthetic lethality; Chromatin remodeling; Epidrugs

    Randomised trial of trastuzumab deruxtecan and biology-driven selection of neoadjuvant treatment for HER2-positive breast cancer: a study protocol of ARIADNE 

    Naume, Bjørn; wildiers, hans; Sonke, Gabe; Karakatsanis, Andreas; Matikas, Alexios; DIECI, MARIA VITTORIA; Villacampa Javierre, Guillermo (Data de publicació: 2025-10-30)

    Breast tumours; Drug therapy

    Spatial TCR clonality and clonal expansion in the in situ microenvironment of non-small cell lung cancer 

    Yu, Hui; Magoulopoulou, Anastasia; Amini, Rose-Marie; Chatzinikolaou, Maria Paraskevi; Horie, Masafumi; Lindberg, Amanda; Mezheyeuski, Artur (Data de publicació: 2025-10-30)

    Clonality; Immune Checkpoint Inhibitor; Lung Cancer

    Metabolic dysfunction-associated steatohepatitis reduces hepatic H2S-producing enzymes altering persulfidome composition 

    SHEN, TZU-KENG; Vignane, Thibaut; Gilglioni, Eduardo Hideo; Traini, Leonardo; Kalaitsidou, Elisavet; Conan, Pierre; Herranz Alzueta, Jose Mari (Data de publicació: 2025-10-30)

    Steatohepatitis; Metabolic dysfunction; Persulfidome

    Fusobacterium nucleatum interacts with cancer-associated fibroblasts to promote colorectal cancer 

    Karta, Jessica; Meyers, Marianne; Rodriguez, Fabien; Koncina, Eric; Gilson, Cédric; Klein, Eliane; Alonso Landeira, Lidia; Aguilera Pujabet, Mònica; Nuciforo, Paolo (Data de publicació: 2025-10-30)

    Fusobacterium nucleatum; Cancer-associated fibroblasts; Colorectal Cancer

    Optimization and validation of the international metabolic prognostic index for CD19 CAR-T in large B-cell lymphoma 

    Winkelmann, Michael; Raj, Sandeep S.; Müller, Fabian; Hansmann, Leo; Jain, Michael; IACOBONI, GLORIA; Barba, Pere (Data de publicació: 2025-10-29)

    Metabolic prognostic index; CD19 CAR-T; Large B-cell lymphoma

    Clinical Validity of FoundationOne Liquid CDx for Detection of BRAFV600E in Colorectal Cancer 

    Martini, Jean-Francois; Pasquina, Lincoln; Tunquist, Brian; Zhang, Xiaosong; Khaiser, Fatima; Yaeger, Rona; Tabernero, Josep (Data de publicació: 2025-10-29)

    BRAF inhibitor; Colorectal cancer